Publications by authors named "Elango Subramoniapillai"

Claim this Profile
G
Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapy.
Nilu Perera, Shoma Baidya, Nicholas Weber, Kari Mudie, Jason Butler, Elango Subramoniapillai

Transfusion· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland, Australia.
Philip Wong, David C Whiteman, Catherine M Olsen, Yin Yuan, Jason Butler, Elango Subramoniapillai

Bone Marrow Transplant· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High incidence of resistant breakthrough invasive fungal infections (IFD) in patients treated for acute gastrointestinal graft-versus-host disease (GI GVHD) following allogeneic haematopoietic cell transplantation.
Yin Yuan, Philip Wong, Jason P Butler, Andrea Henden, Cameron Curley, Elango Subramoniapillai

Bone Marrow Transplant· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lymphoma Alliance.
Stephen Boyle, Joshua W D Tobin, Jacinta Perram, Nada Hamad, Veena Gullapalli, Elango Subramoniapillai

Hemasphere· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis.
Glen A Kennedy, Siok-Keen Tey, Luke Buizen, Antiopi Varelias, Kate H Gartlan, Elango Subramoniapillai

Blood· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation.
Andrea S Henden, Antiopi Varelias, Justine Leach, Elise Sturgeon, Judy Avery, Elango Subramoniapillai

Blood Adv· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mismatched unrelated donor allogeneic stem cell transplant for high risk haematological malignancy: A single centre experience.
Heshani Mediwake, Cameron Curley, Jason Butler, Angela Mclean, Siok Tey, Elango Subramoniapillai

Blood Cancer J· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful use of oseltamivir prophylaxis in managing a nosocomial outbreak of influenza A in a hematology and allogeneic stem cell transplant unit.
Mimi C Yue, Joel T Collins, Elango Subramoniapillai, Glen A Kennedy

Asia Pac J Clin Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.
Glen A Kennedy, Antiopi Varelias, Slavica Vuckovic, Laetitia Le Texier, Kate H Gartlan, Elango Subramoniapillai

Lancet Oncol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis